Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved ...
FDA approves evidence-based tool (Bysanti) to address severe mood and psychotic symptoms, which may predict future indications.
US FDA approves Vanda Pharmaceuticals’ Bysanti to treat bipolar I disorder and schizophrenia: Washington Monday, February 23, 2026, 12:00 Hrs [IST] Vanda Pharmaceuticals Inc., a ...
The U.S. Food and Drug Administration has approved milsaperidone (Bysanti) tablets as a first-line therapy for adults with schizophrenia and manic or mixed episodes of bipolar I disorder, ...
Vanda Pharmaceuticals VNDA shares are trading higher during the premarket session on Monday following the announcement of FDA ...
Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved BYSANTI ...
Femi Akinwumi, professor of educational management, University of Ibadan (UI), will, on Thursday, February 26, deliver the ...
Bid to defame institution and judges: Ramana ...
Congress MP Jairam Ramesh backed the Supreme Court's outrage over critical references to the judiciary in NCERT textbooks, and called for an investigation into what he termed as the RSS's "vile and ...
Professor Femi Akinwumi of the Department of Educational Management will deliver the 605th inaugural lecture of the University of Ibadan on Thursday, 26th February, 2026. The lecture titled: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results